Skip to main content

Pediatric Dermatology News

A recent study highlighted several areas in the United States that lacked a pediatric dermatologist.
A recent study showed that omalizumab was effective for pediatric patients with chronic spontaneous urticaria recalcitrant to first line treatments.
Findings from a recent study showed a drug-device combination product containing cantharidin, 0.7%, was safe and effective for patients with molluscum contagiosum.
Findings from a recent study showed efinaconazole 10% topical solution was safe and effective, with a favorable pharmacokinetic profile, among pediatric patients with onychomycosis.
Findings from a recent study showed an investigational nitric-oxide-releasing topical therapy may effectively treat patients with molluscum contagiosum.
A phase 3 pivotal trial demonstrated superior efficacy of biologic compared with placebo among adolescent patients with atopic dermatitis. For study results and safety, read more.
A new study assessed a specific probiotic mixture as a potential treatment option for children with atopic dermatitis.
Atopic dermatitis, commonly known as eczema, is a widely prevalent disease. In a recent study, researchers aimed to identify subphenotypes of atopic dermatitis in children.
Parent-provided smartphone photographs can be used to help diagnose skin conditions in pediatric patients, according to a recent study.
An oral probiotic formulation may reduce both atopic dermatitis severity and use of topical steroids to treat it in young people with moderate disease, researchers say.
Back to Top